7Baggers
 PHIO PE Ratio & Valuation, Is PHIO Overvalued  Intellectia AI Thu, 02 Jul 2026 17:41:07 GMT
 Phio Pharmaceuticals CEO Robert Bitterman buys $9,900 in stock By Investing.com  Investing.com Nigeria Mon, 29 Jun 2026 20:53:09 GMT
 Form 4 Phio Pharmaceuticals Corp For: 29 June By Investing.com  Investing.com Canada Mon, 29 Jun 2026 20:19:19 GMT
 [Form 4] Phio Pharmaceuticals Corp. Insider Trading Activity  Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
 Phio CEO to pitch INTASYL cancer platform in June 30 webcast  Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
 PHIO Forecast — Price Target — Prediction for 2027  TradingView Thu, 25 Jun 2026 19:08:09 GMT
 Phio Pharmaceuticals Corp. Actuals & Estimates (MUN:44R1)  TradingView Thu, 25 Jun 2026 17:42:04 GMT
 Phio Pharmaceuticals begins commercial-scale production of PH-762  Investing.com Wed, 24 Jun 2026 07:00:00 GMT
 Phio’s PH-762 clears a manufacturing step toward its next trial  Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
 PHIO Should I Buy  Intellectia AI Fri, 19 Jun 2026 07:00:00 GMT
 phio pharmaceuticals corp (phio) institutional confidence  TradingKey Wed, 17 Jun 2026 13:17:06 GMT
 phio pharmaceuticals corp (phio) institutional confidence  TradingKey Tue, 16 Jun 2026 07:00:00 GMT
 phio should i buy  Intellectia AI Fri, 12 Jun 2026 07:00:00 GMT
 number of shareholders of phio pharmaceuticals corp. – mun:44r1  TradingView Wed, 10 Jun 2026 20:23:57 GMT
 PHIO - Phio Pharmaceuticals Corp Short Interest  Finviz Thu, 28 May 2026 07:31:49 GMT
 PHIO - Phio Pharmaceuticals Corp Stock Price and Quote  Finviz Tue, 26 May 2026 11:56:16 GMT
 skin cancer treatment ph-762: phio live q&a session may 28  Stock Titan Tue, 26 May 2026 07:00:00 GMT
 phio pharmaceuticals corp. - common stock (nq:phio)  FinancialContent Fri, 15 May 2026 14:27:55 GMT
 tradingkey  TradingKey Wed, 13 May 2026 18:42:54 GMT
 msn money  MSN Fri, 08 May 2026 06:17:05 GMT
 phio pharmaceuticals q1 net loss widens on higher r&d costs  TradingView Thu, 07 May 2026 20:57:04 GMT
 Phio Pharmaceuticals | 10-Q: Q1 2026 Earnings Report  Moomoo Thu, 07 May 2026 07:00:00 GMT
 skin cancer drug trial wraps at phio, fda submission targets q2  Stock Titan Thu, 07 May 2026 07:00:00 GMT
 msn money  MSN Thu, 07 May 2026 07:00:00 GMT
 msn money  MSN Wed, 06 May 2026 22:10:45 GMT
 phio q1'26 earnings: eps estimate is (0.23) usd  TradingView Wed, 06 May 2026 11:02:03 GMT
 msn money  MSN Sun, 03 May 2026 13:18:56 GMT
 msn money  MSN Sat, 02 May 2026 16:40:21 GMT
 rna therapies clinical trial pipeline gains momentum: 20+  openPR.com Mon, 27 Apr 2026 07:00:00 GMT
 user  The Chronicle-Journal Mon, 13 Apr 2026 11:00:00 GMT
 phio spotlights skin cancer candidate after 65% response rate  Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
 form 8-k - current report  ADVFN Sat, 11 Apr 2026 13:35:03 GMT
 phio pharmaceuticals establishes new at-the-market equity program  The Globe and Mail Thu, 09 Apr 2026 07:00:00 GMT
 phio pharmaceuticals (phio) files $6.36m atm with h.c. wainwright  Stock Titan Wed, 08 Apr 2026 07:00:00 GMT
 phio pharmaceuticals secures cgmp manufacturing for clinical supply  The Globe and Mail Tue, 31 Mar 2026 12:28:00 GMT
 phio pharmaceuticals secures u.s. cgmp manufacturer for ph-762 clinical and commercial supply  TradingView — Track All Markets Mon, 30 Mar 2026 11:23:01 GMT
 dow update: can phio pharmaceuticals corp lead its sector in growth  baoquankhu1.vn Sat, 28 Mar 2026 20:14:37 GMT
 phio pharmaceuticals corp (44r1.mu) stock price, news, quote & history  Yahoo! Finance Canada Sat, 28 Mar 2026 17:19:22 GMT
 phio pharmaceuticals to present ph-762 cancer trial data friday  Investing.com Mon, 23 Mar 2026 07:00:00 GMT
 phio cancer study sees ~65% response; ceo in march 18 virtual chat  Stock Titan Mon, 16 Mar 2026 07:00:00 GMT
 sidoti boosts earnings estimates for phio pharmaceuticals  Defense World Fri, 13 Mar 2026 05:12:11 GMT
 phio pharmaceuticals corp. financial disclosures & sec filings  TradingView Wed, 11 Mar 2026 07:07:27 GMT
 cancer gene-silencing trial shows 65% response in phio study  Stock Titan Tue, 10 Mar 2026 07:00:00 GMT

Phio Pharmaceuticals Corp
(NASDAQ:PHIO) 

PHIO stock logo

Phio Pharmaceuticals Corp., a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762, which targets the checkpoint protein PD-1 that pre...

Founded: 2011
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends